Amy Bastille

机构：Io Therapeutics (United States)

发表论文 2 篇 · 总被引 25 次 · h-index 2

代表论文

• Genome editing without nucleases confers proliferative advantage to edited hepatocytes and corrects Wilson disease (2023 · JCI Insight · 被引 17)
• Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmalonic acidemia (2022 · PLoS ONE · 被引 8)